Treating sexual desire disorders with flibanserin
AssigneeSprout Pharmaceuticals, Inc.
InventorsFranco Borsini, Kenneth Robert Evans
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of flibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.
Claims20
A method of treating decreased sexual desire in an adult human patient, comprising orally administering one or more capsule or tablet comprising a therapeutically effective amount of flibanserin or a pharmaceutically acceptable acid addition salt thereof, and at least one excipient, to the patient to treat decreased sexual desire.
A method of treating absent sexual desire in an adult human patient, comprising orally administering one or more capsule or tablet comprising a therapeutically effective amount of flibanserin or a pharmaceutically acceptable acid addition salt thereof, and at least one excipient, to the patient to treat decreased sexual desire.
A method of treating inhibited sexual desire in an adult human patient, comprising orally administering one or more capsule or tablet comprising a therapeutically effective amount of flibanserin or a pharmaceutically acceptable acid addition salt thereof, and at least one excipient, to the patient to treat decreased sexual desire.
Dependencies are inferred from the claim text.